Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two independent epigenetic biomarkers predict survival in neuroblastoma.
Yáñez Y, Grau E, Rodríguez-Cortez VC, Hervás D, Vidal E, Noguera R, Hernández M, Segura V, Cañete A, Conesa A, Font de Mora J, Castel V. Yáñez Y, et al. Among authors: font de mora j. Clin Epigenetics. 2015 Feb 27;7(1):16. doi: 10.1186/s13148-015-0054-8. eCollection 2015. Clin Epigenetics. 2015. PMID: 25767620 Free PMC article.
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
Sanmartín E, Muñoz L, Piqueras M, Sirerol JA, Berlanga P, Cañete A, Castel V, Font de Mora J. Sanmartín E, et al. Among authors: font de mora j. Clin Cancer Res. 2017 Nov 15;23(22):6875-6887. doi: 10.1158/1078-0432.CCR-17-0593. Epub 2017 Aug 22. Clin Cancer Res. 2017. PMID: 28830922
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
Berlanga P, Muñoz L, Piqueras M, Sirerol JA, Sánchez-Izquierdo MD, Hervás D, Hernández M, Llavador M, Machado I, Llombart-Bosch A, Cañete A, Castel V, Font de Mora J. Berlanga P, et al. Among authors: font de mora j. Mol Oncol. 2016 Aug;10(7):1043-53. doi: 10.1016/j.molonc.2016.04.004. Epub 2016 Apr 23. Mol Oncol. 2016. PMID: 27155790 Free PMC article.
TIAM1 variants improve clinical outcome in neuroblastoma.
Sanmartín E, Yáñez Y, Fornés-Ferrer V, Zugaza JL, Cañete A, Castel V, Font de Mora J. Sanmartín E, et al. Among authors: font de mora j. Oncotarget. 2017 Jul 11;8(28):45286-45297. doi: 10.18632/oncotarget.16787. Oncotarget. 2017. PMID: 28423360 Free PMC article.
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.
Gargallo P, Oltra S, Tasso M, Balaguer J, Yáñez Y, Dolz S, Calabria I, Martínez F, Segura V, Juan-Ribelles A, Llavador M, Castel V, Cañete A, Font de Mora J. Gargallo P, et al. Among authors: font de mora j. Eur J Hum Genet. 2022 Nov;30(11):1288-1291. doi: 10.1038/s41431-022-01105-x. Epub 2022 Apr 22. Eur J Hum Genet. 2022. PMID: 35459888 Free PMC article.
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.
Juan Ribelles A, Barberá S, Yáñez Y, Gargallo P, Segura V, Juan B, Noguera R, Piqueras M, Fornés-Ferrer V, Font de Mora J, Cañete A, Castel V. Juan Ribelles A, et al. Among authors: font de mora j. Sci Rep. 2020 Jan 31;10(1):1914. doi: 10.1038/s41598-020-58428-2. Sci Rep. 2020. PMID: 32005943 Free PMC article.
55 results